
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Taysha Gene Therapies is a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system. Its lead clinical program TSHA-102 is in development for Rett syndrome, a rare neurodevelopmental disorder with no approved disease-modifying therapies that address the genetic root cause of the disease. With a singular focus on developing transformative medicines, Taysha aims to address severe unmet medical needs and dramatically improve the lives of patients and their caregivers. The Companys management team has proven experience in gene therapy development and commercialization. Taysha leverages this experience, its manufacturing process...
Gene therapy,central nervous system,and molecular biology
Taysha gene therapies operates in the Biotechnology industry.
Taysha gene therapies's revenue is 1m - 10m
Taysha gene therapies has 51 - 200 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.